Blue Trust Inc. Grows Stock Holdings in The Allstate Co. (NYSE:ALL)

Blue Trust Inc. raised its holdings in shares of The Allstate Co. (NYSE:ALL) by 90.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,989 shares of the insurance provider’s stock after acquiring an additional 1,419 shares during the quarter. Blue Trust Inc.’s holdings in Allstate were worth $567,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Northwest Investment Counselors LLC bought a new position in Allstate in the 1st quarter worth about $26,000. Versant Capital Management Inc boosted its position in shares of Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 78 shares during the period. Family Firm Inc. purchased a new position in Allstate during the second quarter valued at approximately $38,000. MCF Advisors LLC increased its holdings in Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares during the period. Finally, First Command Advisory Services Inc. purchased a new stake in Allstate in the 2nd quarter worth approximately $58,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Insider Buying and Selling

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the completion of the sale, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at $3,431,901.67. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 192,530 shares of company stock valued at $34,967,665 over the last ninety days. 1.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on ALL shares. StockNews.com lowered shares of Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. JPMorgan Chase & Co. upped their target price on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. Raymond James lifted their price target on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research report on Friday, October 4th. UBS Group boosted their price objective on Allstate from $215.00 to $216.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Finally, Jefferies Financial Group raised their target price on shares of Allstate from $217.00 to $231.00 and gave the company a “buy” rating in a research note on Wednesday, October 9th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Allstate has an average rating of “Moderate Buy” and a consensus price target of $206.44.

Allstate Stock Performance

NYSE:ALL opened at $192.64 on Tuesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.36 and a current ratio of 0.36. The Allstate Co. has a fifty-two week low of $121.70 and a fifty-two week high of $198.79. The firm has a market cap of $50.84 billion, a PE ratio of 42.53, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The business has a 50 day moving average price of $187.08 and a 200-day moving average price of $173.96.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business had revenue of $15.71 billion during the quarter, compared to analysts’ expectations of $14.04 billion. During the same quarter in the prior year, the company posted ($4.42) EPS. The firm’s revenue for the quarter was up 12.4% compared to the same quarter last year. Equities research analysts predict that The Allstate Co. will post 15.19 earnings per share for the current year.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.